Managing Myeloma
- 2009-08-31 - Keryx Biopharmaceuticals, Inc. To Present at the Rodman & Renshaw Annual Global Investment...
- 2009-08-27 - Start of the first phase II clinical trial with monoclonal antibody IPH 2101 supported by a new 2.9 million euros financing from OSEO
- 2009-08-25 - Key Role for Bisphosphonates in Reducing Myeloma Bone Damage
- 2009-08-25 - Mayo Clinic Proceedings: Common Blood Disorder May Not be Linked to as Many Serious Diseases, as Previously Thought
- 2009-08-25 - New drugs may change the role of transplant in treatment of myeloma
- 2009-08-25 - Lawyer Says Drugmaker Celgene Stole Her Idea-Forbes
- 2009-08-21 - Pomalidomide Active for Treatment of Anemia of Myelofibrosis
- 2009-08-20 - Managing Myeloma Website Launches an Interactive Forum for Oncology Nurses, Wins 2009 Gold Hermes Creative Award for Site Overall PR Newswire (press release)
- 2009-08-20 - Bone marrow patient meets donor
- 2009-08-17 - Father’s memory inspires family
- 2009-08-17 - Local foundation strides for a cure
- 2009-08-17 - Oncology Nurses Can Shine as Number of PCPs, Oncologists Run Low
- 2009-08-14 - Possible Genetic Links Between Environmental Toxins And Multiple Myeloma
- 2009-08-14 - Drugmaker Can’t Find Patients To Test, But No Worries
- 2009-08-14 - Immunomedics Gets FDA Nod To Begin Human Studies On Cancer Drug Candidate Milatuzumab-doxorubicin Conjugate – Update